Hydrocortisone cardioprotection in ischaemia/reperfusion injury involves antioxidant mechanisms

被引:2
|
作者
Escudero, Daiana S. [1 ,2 ]
Fantinelli, Juliana C. [1 ,3 ]
Martinez, Valeria R. [1 ,3 ]
Arbelaez, Luisa F. Gonzalez [1 ,3 ]
Amarillo, Maria E. [1 ,4 ]
Perez, Nestor G. [1 ,3 ]
Diaz, Romina G. [1 ,3 ]
机构
[1] Univ Nacl La Plata, Fac Ciencias Med Plata, Ctr Invest Cardiovasc Dr Horacio E Cingolani, La Plata, Argentina
[2] Established Investigator Comis Invest Cient CIC, Buenos Aires, Argentina
[3] Established Investigators Consejo Nacl Invest Cien, Buenos Aires, Argentina
[4] Agencia Nacl Promoc Cient & Tecnol Agencia I D i, Buenos Aires, Argentina
关键词
AKT; cardioprotection; glucocorticoids; myocardial infarction; NHE1; oxidative stress; ISCHEMIA-REPERFUSION INJURY; CARDIAC-SURGERY; HEART; CORTICOSTEROIDS; PREVENTION; GLUCOCORTICOIDS; ASSOCIATION; INHIBITION; ACTIVATION; APOPTOSIS;
D O I
10.1111/eci.14172
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundGlucocorticoid (GR) and mineralocorticoid (MR) receptors are highly expressed in cardiac tissue, and both can be activated by corticosteroids. MR activation, in acute myocardial infarction (AMI), worsens cardiac function, and increase NHE activity contributing to the deleterious process. In contrast, effects of GR activation are not fully understood, probably because of the controversial scenario generated by using different doses or potencies of corticosteroids.AimsWe tested the hypothesis that an acute dose of hydrocortisone (HC), a low-potency glucocorticoid, in a murine model of AMI could be cardioprotective by regulating NHE1 activity, leading to a decrease in oxidative stress.Materials and MethodsIsolated hearts from Wistar rats were subjected to regional ischemic protocol. HC (10 nmol/L) was added to the perfusate during early reperfusion. Infarct size and oxidative stress were determined. Isolated papillary muscles from non-infarcted hearts were used to evaluate HC effect on sodium-proton exchanger 1 (NHE1) by analysing intracellular pH recovery from acute transient acidosis.ResultsHC treatment decreased infarct size, improved cardiac mechanics, reduced oxidative stress after AMI, while restoring the decreased level of the pro-fusion mitochondrial protein MFN-2. Co-treatment with the GR-blocker Mifepristone avoided these effects. HC reduced NHE1 activity by increasing the NHE1 pro-inhibiting Ser648 phosphorylation site and its upstream kinase AKT. HC restored the decreased AKT phosphorylation and anti-apoptotic BCL-2 protein expression detected after AMI.ConclusionsOur results provide the first evidence that acute HC treatment during early reperfusion induces cardioprotection against AMI, associated with a non-genomic HC-triggered NHE1 inhibition by AKT and antioxidant action that might involves mitochondrial dynamics improvement. Possible nongenomic protective pathways induced by acute HC treatment during I/R. GR activation preserves MFN-2 decreasing oxidative stress. Through GR-independent pathway, HC promotes an AKT-mediated inhibitory NHE1 phosphorylation (Ser 648), preventing sodium-triggered calcium overload and thus MPTP opening leading to cardioprotection.image
引用
收藏
页数:14
相关论文
共 50 条
  • [21] Myocardial ischaemia reperfusion injury and cardioprotection in the presence of sensory neuropathy: Therapeutic options
    Bencsik, Peter
    Gomori, Kamilla
    Szabados, Tamara
    Santha, Peter
    Helyes, Zsuzsanna
    Jancso, Gabor
    Ferdinandy, Peter
    Gorbe, Aniko
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (23) : 5336 - 5356
  • [22] Synthetic torpor confers cardioprotection against myocardial ischaemia/reperfusion injury in the rat
    Khan, M. Ali
    Taddei, L.
    Elley, M.
    Wilcox, R.
    Pickering, A.
    Ambler, M.
    EUROPEAN HEART JOURNAL, 2024, 45
  • [23] Adenosine and cardioprotection during ischaemia and reperfusion - an overview
    Sommerschild, HT
    Kirkeboen, KA
    ACTA ANAESTHESIOLOGICA SCANDINAVICA, 2000, 44 (09) : 1038 - 1055
  • [24] Mechanisms of Cardioprotection of Subcellular Defects in Ischemia-reperfusion Injury
    Dhalla, N. S.
    Bartekova, M.
    Elimban, V.
    CORONARY ARTERY DISEASE 2015, 2016, : 1 - 6
  • [25] Comparison of femoral and aortic remote ischaemia preconditioning for cardioprotection against myocardial ischaemia/reperfusion injury in a rat model
    Chai, Qing
    Liu, Jin
    Hu, Yang
    INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 2014, 19 (06) : 1013 - 1018
  • [26] Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction
    Gerhard R. Situmorang
    Neil S. Sheerin
    Pediatric Nephrology, 2019, 34 : 951 - 963
  • [27] The protective mechanisms of defibrotide on liver ischaemia-reperfusion injury
    Aydemir, EO
    Var, A
    Uyanik, BS
    Ilkgül, Ö
    Aydede, H
    Sakarya, A
    CELL BIOCHEMISTRY AND FUNCTION, 2003, 21 (04) : 307 - 310
  • [28] Novel signalling mechanisms and targets in renal ischaemia and reperfusion injury
    Kusch, A.
    Hoff, U.
    Bubalo, G.
    Zhu, Y.
    Fechner, M.
    Schmidt-Ullrich, R.
    Marko, L.
    Mueller, D. N.
    Schmidt-Ott, K. M.
    Guergen, D.
    Blum, M.
    Schunck, W. -H.
    Dragun, D.
    ACTA PHYSIOLOGICA, 2013, 208 (01) : 25 - 40
  • [29] Ischaemia reperfusion injury in liver transplantation: Cellular and molecular mechanisms
    Dar, Wasim A.
    Sullivan, Elise
    Bynon, John S.
    Eltzschig, Holger
    Ju, Cynthia
    LIVER INTERNATIONAL, 2019, 39 (05) : 788 - 801
  • [30] Ischaemia reperfusion injury: mechanisms of progression to chronic graft dysfunction
    Situmorang, Gerhard R.
    Sheerin, Neil S.
    PEDIATRIC NEPHROLOGY, 2019, 34 (06) : 951 - 963